Johnson & Johnson

+$1.12 (+0.63%) As of 4:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices.

CEO

Joaquin Duato

Employees

141,700

Headquarters

New Brunswick, New Jersey

Founded

1887

JNJ Key Statistics

Market cap

Price-Earnings ratio

23.83

Dividend yield

2.44

Average volume

8.81M

High today

$178.30

Low today

$176.91

Open price

$177.22

Volume

2.83M

52 Week high

$186.69

52 Week low

$155.72

JNJ News

The Wall Street Journal2h

General Mills Sales Climb 8% on Higher Prices

MarketWatch Johnson & Johnson does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE and Pfizer Inc. , and N

MarketWatchJun 24

Johnson & Johnson's Janssen: CHMP Backs Expanded Imbruvica Use in Chronic Lymphocytic Leukemia - MarketWatch

By Colin Kellaher Johnson & Johnson's Janssen Pharmaceutical Cos. unit on Friday said the European Medicines Agency's Committee for Medicinal Products for Huma

ReutersJun 23

How a bankruptcy 'innovation' halted thousands of lawsuits from sick plaintiffs - Reuters

Attorney Greg Gordon sat before a packed hotel ballroom of bankruptcy lawyers who had come to hear him hold court on his pioneering strategy for companies seeki

Analyst ratings

Buy

36.8%

Hold

57.9%

Sell

5.3%

JNJ Earnings

$0.00

$0.89

$1.78

$2.67

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Available Jul 19, Pre-Market

More JNJ News

BenzingaJun 23

Here's How Much You Would Have Made Owning Johnson & Johnson Stock In The Last 15 Years

Johnson & Johnson JNJ has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 7.34%. Currently,